RIVFLOZA
Live / Registered — Registered (as of 20 Aug 2024)
What this means for you
Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90191150
- Registration number
- 7482490
- Mark type
- Stylized text
- Filed
- 18 Sept 2020
- Published for opposition
- 08 Mar 2022
- Registered
- 20 Aug 2024
- Attorney of record
- Spencer Beall
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of various diseases, namely, pharmaceutical preparations for the treatment of rare diseases in the nature of genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; drug delivery agents in the nature of oligonucleotide compounds for use in the targeted delivery of RNAi therapy; chemical compounds that act as a platform for the delivery of drugs in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
- Class 042 — Scientific and technological services: Scientific research and development of pharmaceutical preparations, compounds for use in the targeted delivery of therapy, chemical compounds that act as a platform for the delivery of drugs, and drug delivery agents; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- NOVO NORDISK HEALTH CARE AG, Zürich, CH
- NOVO NORDISK HEALTH CARE AG, Zürich, CH
- Dicerna Pharmaceuticals, Inc., Lexington, MA, US
- Dicerna Pharmaceuticals, Inc., Lexington, MA, US
Prosecution history
- 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 16 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 08 May 2024 — USE AMENDMENT FILED
- 12 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 04 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 May 2024 — SOU EXTENSION 4 GRANTED
- 03 May 2024 — SOU EXTENSION 4 FILED
- 03 May 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Oct 2023 — SOU EXTENSION 3 GRANTED
- 19 Oct 2023 — SOU EXTENSION 3 FILED